Diode laser transscleral cyclophotocoagulation for refractory glaucoma
- VernacularTitle:半导体激光经巩膜睫状体光凝治疗难治性青光眼
- Author:
Jianfeng XU
;
Xuexi LI
;
Dongping PAN
- Publication Type:Journal Article
- Keywords:
diode laser;
transscleral cyclophotocoagulation;
glaucoma
- From:
Recent Advances in Ophthalmology
2001;21(3):177-178
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical efficiency of diode laser transscleral cyclophotocoagulation(TSCPC) for the treatment of refractory glaucoma.Methods TSCPC were performed in 23 eyes of 23 patients with medically and surgically uncontrolled glaucoma. The laser was operated with a power of 2～3W,duration of 1.5～2s and laser spots(18) were evenly placed 270 around the limbus except temporal. Followed for 3～24 months (average:11 months) . Results The mean intraocular pressure before and after treatment in 23 eyes were 6.10kPa±2.34kPa and 2.55kPa±1.22kPa respectively,which was statistically significant (P<0.01). IOP below 2.80kPa was obtained in 20 eyes (86.9%). At the time of last visit,the post-operative visual acuity was partly improved besides NLP.Conclusion Diode laser transscleral cyclophotocoagulation is effective in treating refractory glaucoma. Its advantages are low ratio of ocular hypotension,no atrophy of eyeball,no pain, acceptability,reoperation and therapeuty in clinic and so on.
